Open Access<p>Treatment of Recurrent <em>Clostridioides difficile</em> Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease</p>
Author(s) -
Masoumeh Azimirad,
Abbas Yadegar,
Fatemeh Gholami,
Shabnam Shahrokh,
Hamid Asadzadeh Aghdaei,
Gianluca Ianiro,
Hideji Suzuki,
Giovanni Cammarota,
Mohammad Reza Zali
Publication year - 2020
Publication title -
journal of inflammation research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.656
H-Index - 33
ISSN - 1178-7031
DOI - 10.2147/jir.s265520
Subject(s) - clostridioides , fecal bacteriotherapy , inflammatory bowel disease , medicine , gastroenterology , feces , transplantation , gut flora , disease , immunology , clostridium difficile , antibiotics , biology , microbiology and biotechnology
Fecal microbiota transplantation (FMT) is an effective treatment option for patients with recurrent Clostridioides difficile infection (rCDI). However, there is a paucity of evidence regarding its efficacy and safety in patients with rCDI and concurrent inflammatory bowel disease (IBD). Here, we present a single-center experience of FMT for treatment of rCDI in Iranian patients with IBD.